Comparison of two algorithms to support medication surveillance for drug-drug interactions between QTc-prolonging drugs
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in International Journal of Medical Informatics
- Vol. 145, 104329
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Development of a risk model for predicting QTc interval prolongation in patients using QTc-prolonging drugsInternational Journal of Clinical Pharmacy, 2018
- Development of a risk score for QTc-prolongation: the RISQ-PATH studyInternational Journal of Clinical Pharmacy, 2017
- Predicting the UnpredictableJACC, 2016
- Are ECG monitoring recommendations before prescription of QT‐prolonging drugs applied in daily practice? The example of haloperidolPharmacoepidemiology and Drug Safety, 2015
- Refining repolarization reserveHeart Rhythm, 2011
- Accurate electrocardiographic assessment of the QT interval: Teach the tangentHeart Rhythm, 2008
- Inaccurate electrocardiographic interpretation of long QT: The majority of physicians cannot recognize a long QT when they see oneHeart Rhythm, 2005
- Prolonged QTc Interval and Risks of Total and Cardiovascular Mortality and Sudden Death in the General PopulationArchives of internal medicine (1960), 2004
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Drug induced QT prolongation and torsades de pointesHeart, 2003